Phase 1 dose-escalation, pharmacokinetic, and cerebrospinal fluid distribution study of TAK-285, an investigational inhibitor of EGFR and HER2

Overview of attention for article published in Investigational New Drugs, July 2013

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 5 followers.

Phase 1 dose-escalation, pharmacokinetic, & cerebrospinal fluid distribution study of TAK-285, an investigational... http://t.co/zms5ergki7

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.